Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Immunowake, Inc. logo — Immunowake Inc. is a private, pre-clinical stage biotechnolo...

Immunowake, Inc.

Immunowake Inc. is a private, pre-clinical stage biotechnology company focused on cancer drug discovery.

Founded 2019 United States Birmingham, United States 2 employees Series A Total: $23.00M Biotechnology

General Information

Company Name Immunowake, Inc.
Founded Year 2019
Location United States Birmingham, United States +1
Employees 2
Industries Biotechnology
Funding Stage Series A
Social

Get notified when Immunowake, Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Immunowake, Inc.

Immunowake, Inc. is a private, pre-clinical stage biotechnology company focused on cancer drug discovery. The company's strategy involves harnessing the body’s immune system to identify and kill cancer cells, similar to the way pathogens are targeted. Recent breakthroughs in cancer immunotherapy have shown that activating antigen-specific T-cells can lead to powerful anti-tumor responses.

Founded in 2019 and headquartered in the United States, Immunowake recently received a $20.00M Series A investment on May 15, 2022. The investment was made by Hyfinity Investments, South China VC, Lapam Capital, and HEDA VENTURES.

Taxonomy: cancer drug discovery, immunotherapy, cancer immunotherapy, pre-clinical stage, antigen-specific T-cells, immune system, anti-tumor responses, cancer treatment, cancer therapies

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series A •••••• 4
Investor Investor Investor Investor
15 May 2022
Seed Round •••••• - 22 Aug 2019

Immunowake, Inc. Alternatives & Competitors

Immunowake, Inc. vs
Caedo Oncology AS
Caedo Oncology AS Norway

We create improved treatment options for cancer patients through unique immunotherapy opportunities

Series Unknown
6 employees
Biotechnology, Health Care
Immunowake, Inc. vs
ImmunoCellular Therapeutics Ltd
ImmunoCellular Therapeutics Ltd United States

Pioneering immune-based therapies to harness the body's defenses against cancer through advanced imm...

Grant
11 employees
Biotechnology, Health Care
Immunowake, Inc. vs
Vaxon Biotech
Vaxon Biotech

Therapeutic vaccines empowering your immune system to target cancer without harming healthy cells, f...

3 employees
Biotechnology, Health Care
Also compare with: Immunowake, Inc. vs NextCure, Inc. NextCure, Inc.

FAQ About Immunowake, Inc.

Immunowake Inc. is a private, pre-clinical stage biotechnology company focused on cancer drug discovery.
Immunowake, Inc. was founded in 2019.
Immunowake, Inc. is headquartered in Birmingham, United States.
Immunowake, Inc. operates in the following industries: Biotechnology.
Immunowake, Inc. has approximately 2 employees.
Immunowake, Inc. has completed 2 funding rounds, raising a total of $23.00M. The latest funding stage is Series A.
Top alternatives and competitors to Immunowake, Inc. include Caedo Oncology AS, ImmunoCellular Therapeutics Ltd, Vaxon Biotech, ALKemist Bio, Stellanova Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Immunowake, Inc. and Caedo Oncology AS are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Immunowake, Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy